A new method to evaluate oxidative stress in humans

Immuno-Analyse et Biologie Specialisee

Volumn 17, Issue 3, 2002, Pages 172-175

  Lubrano, V ^a   Vassalle, C ^a   L'Abbate, A ^a   Zucchelli, G C ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

8 iso PGF 2 ; Free radicals; Hydroperoxide; Lipid peroxidation; Stress oxidative

Indexed keywords

ADSORPTION; ADULT; ARTICLE; BODY FLUID; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; EXTRACTION; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0010457365     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(02)01188-2     Document Type: Article

References (17)

1. Alberti A., Bolognini L., Macciantelli D., Carratelli M. The radical cation of N,N-diethyl-para-phenylendiamine: a possible indicator of oxidative stress in biological samples. Res Chem Interm. 26:2000;253-267.
2. Banerjee M., Kang K.H., Morrow J.D., Roberts L.J., Newman J.H. Effects of a novelprostaglandin, 8-epi-PGF2α, in rabbit lung in situ. Am J Physiol. 263:1992;H660-H663.
3. Bauersachs J., Fleming I., Fraccarollo D., Busse R., Ertl G. Prevention of endothelial dysfunction in heart failure by vitamin E: attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression. Cardiovasc Res. 51:2001;344-350.
4. Capani F., Loidl C.F., Aguirre F., Piehl L., Facorro G., Hager A., De Paoli T., Farach H., Pecci-Saavedra J. Changes in reactive oxygen species (ROS) production in rat brain during global perinatal asphyxia: an ESR study. Brain Res. 914:2001;204-207.
5. Colev V., Paduraru I., Vornicu M., Badescu M., Mocanu V., Ciocoiu M., Saramet A., Bohotin C. The reduction of dyslipidemia and oxidative stress in experimental diabetes mellitus treated with probucol. Rev Med Chir Soc Med Nat Iasi. 101:1997;103-107.
6. Cracowski J.L., Stanke-Labesque F., Souvignet C., Bessard G. Isoprostanes: new markers of oxidative stress in human diseases. Presse M. 29:2000;604-610.
7. Doshi S.N., McDowell I.F., Moat S.J., Lang D., Newcombe R.G., Kredan M.B., Lewis M.J., Goodfellow J. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol. 21:2001;1196-1202.
8. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol M. 11:1991;81-128.
9. Esterbauer H., Cheeseman K.H. Determination of aldheydic lipidic peroxidation product: malonaldeyde and 4-hdroxynonenal. Meth Enzimol. 186:1990;407.
10. Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., Channon K.M. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 86:2000;E85-E90.
11. Haffner S.M. Clinical relevance of the oxidative stress concept. Metabolism. 49:2000;30-34.
12. Indik J.H., Goldman S., Gaballa M.A. Oxidative stress contributes to vascular endothelial dysfunction in heart failure. Am J Physiol Heart Circ Physiol. 281:2001;H1767-H1770.
13. Jackson M.J. An overview of methods for assessment of free radical activity in biology. Proc Nutr Soc. 58:1999;1001-1006.
14. Liu T., Stern A., Roberts L.J., Morrow J.D. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J Biomed Sci. 6:1999;226-235.
15. Maxwell S.R., Lip G.Y. Free radicals and antioxidants in cardiovascular disease. Br J Clin Pharmacol. 44:1997;307-317.
16. Patrono C., FitzGerald G.A. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol. 17:(11):1997;2309-2315.
17. Pratico D., Lawson J.A., Rokach J., FitzGerald G.A. The isoprostanes in biology and medicine. Trends Endocrinol Metab. 12:2001;243-247.